Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth
Category: Equity: Sectoral-Pharma and Healthcare
Launch Date: 05-07-2019
AUM:
₹ 950.07 Cr
Expense Ratio
2.25%
Benchmark
BSE Healthcare TRI
ISIN
INF209KB1N91
Minimum Investment
1000.0
Minimum Topup
1000.0
Minimum SIP Amount
100
Fund Manager
Mr. Dhaval Shah
| Fund Performance | 1Y (%) | 3Y (%) | 5Y (%) |
|---|---|---|---|
| Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth | 11.09 | 23.56 | 12.78 |
| Benchmark | - | - | - |
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
Overview
NAV
33.56
Last change
0.32 (0.9535%)
Fund Size (AUM)
₹ 950.07 Cr
Performance
19.04% (Inception)
Asset Allocation
Equity
Debt
Others
Nav Movement
Investment Objective
The scheme provides long term capital appreciation by investing in equity/equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India. The Scheme does not guarantee/indicate any returns. There can be no assurance that the schemes’ objectives will be achieved.
Fund Manager
Mr. Dhaval Shah
Riskometer
Very High
Top 10 Holdings
| Company | Holdings (%) |
|---|---|
| SUN PHARMACEUTICAL INDUSTRIES LTD. EQ NEW F.V. RE.1/- | 13.17 |
| APOLLO HOSPITALS ENTERPRISE LIMITED EQ NEW F.V. RS.5/- | 7.2 |
| TORRENT PHARMACEUTICALS LIMITED EQ NEW FV RS.5/- | 4.76 |
| JB Chemicals & Pharmaceuticals Limited | 4.71 |
| AUROBINDO PHARMA LIMITED EQ NEW F.V. RE.1/- | 4.49 |
| AJANTA PHARMA LIMITED EQ NEW FV RS. 2/- | 4.05 |
| LUPIN LIMITED EQ NEW F.V. RS.2/- | 4.0 |
| MANKIND PHARMA LIMITED EQ NEW FV RE. 1/- | 3.88 |
| FORTIS HEALTHCARE LIMITED. EQ | 3.87 |
| ABBOTT INDIA LIMITED EQ | 3.65 |
Sector Allocation
| Sector | Holdings (%) |
|---|---|
| Healthcare | 96.92 |
| Financial Services | 1.0 |
| Chemicals | 0.69 |
Peer Comparison
| Scheme Name | 5Y (%) |
|---|---|
| ABSL Pharma and Healthcare Reg Gr | 12.78 |